{"database": "lobbying", "table": "lobbying_activities", "rows": [[2185817, "c92bba0a-69dd-414a-8f42-2e8b4b1e9f91", "Q3", "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 3457, "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 2018, "third_quarter", "PHA", "Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with Congress on compounding. Communicated with House and Senate offices on drug shortages.Communication with DEA on opioid shortage of generic injectables. Support for S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2018, and H.R. 6142, Reducing Drug Waste Act of 2018.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", null, 290000, 0, 0, "2018-10-16T14:22:28.587000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2185817"], "units": {}, "query_ms": 1.9624759443104267, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}